Year |
Citation |
Score |
2021 |
Belmontes B, Sawant DV, Zhong W, Tan H, Kaul A, Aeffner F, O'Brien SA, Chun M, Noubade R, Eng J, Ma H, Muenz M, Li P, Alba BM, Thomas M, et al. Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors. Science Translational Medicine. 13. PMID 34433637 DOI: 10.1126/scitranslmed.abd1524 |
0.445 |
|
2021 |
Bhatt D, Kang B, Sawant D, Zheng L, Perez K, Huang Z, Sekirov L, Wolak D, Huang JY, Liu X, DeVoss J, Manzanillo PS, Pierce N, Zhang Z, Symons A, et al. STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets. The Journal of Experimental Medicine. 218. PMID 33900375 DOI: 10.1084/jem.20201329 |
0.394 |
|
2020 |
Zhang L, Li Z, Skrzypczynska KM, Fang Q, Zhang W, O'Brien SA, He Y, Wang L, Zhang Q, Kim A, Gao R, Orf J, Wang T, Sawant D, Kang J, et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell. 181: 442-459.e29. PMID 32302573 DOI: 10.1016/J.Cell.2020.03.048 |
0.442 |
|
2020 |
Sullivan JA, Tomita Y, Jankowska-Gan E, Lema DA, Arvedson MP, Nair A, Bracamonte-Baran W, Zhou Y, Meyer KK, Zhong W, Sawant DV, Szymczak-Workman AL, Zhang Q, Workman CJ, Hong S, et al. Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance. Cell Reports. 30: 1039-1051.e5. PMID 31995748 DOI: 10.1016/J.Celrep.2019.12.081 |
0.448 |
|
2019 |
Sawant DV, Yano H, Chikina M, Zhang Q, Liao M, Liu C, Callahan DJ, Sun Z, Sun T, Tabib T, Pennathur A, Corry DB, Luketich JD, Lafyatis R, Chen W, et al. Adaptive plasticity of IL-10 and IL-35 T cells cooperatively promotes tumor T cell exhaustion. Nature Immunology. PMID 30936494 DOI: 10.1038/S41590-019-0346-9 |
0.54 |
|
2017 |
Vogel P, Janke L, Gravano DM, Lu M, Sawant DV, Bush D, E S, Vignali DAA, Pillai A, Rehg JE. Globule Leukocytes and Other Mast Cells in the Mouse Intestine. Veterinary Pathology. 300985817705174. PMID 28494703 DOI: 10.1177/0300985817705174 |
0.436 |
|
2016 |
Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DA. Interleukin-35 Limits Anti-Tumor Immunity. Immunity. 44: 316-29. PMID 26872697 DOI: 10.1016/J.Immuni.2016.01.013 |
0.519 |
|
2015 |
Sawant DV, Hamilton K, Vignali DA. Interleukin-35: Expanding Its Job Profile. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 499-512. PMID 25919641 DOI: 10.1089/Jir.2015.0015 |
0.45 |
|
2015 |
Sawant DV, Yao W, Wright Z, Sawyers C, Tepper RS, Gupta SK, Kaplan MH, Dent AL. Serum MicroRNA-21 as a Biomarker for Allergic Inflammatory Disease in Children. Microrna (Shariqah, United Arab Emirates). PMID 25707810 |
0.498 |
|
2015 |
Sawant DV, Dent AL. It takes CK2 to suppress TH2. Nature Immunology. 16: 224-5. PMID 25689435 DOI: 10.1038/Ni.3104 |
0.678 |
|
2015 |
Sawant DV, Wu H, Yao W, Sehra S, Kaplan MH, Dent AL. The transcriptional repressor Bcl6 controls the stability of regulatory T cells by intrinsic and extrinsic pathways. Immunology. 145: 11-23. PMID 25262912 DOI: 10.1111/Imm.12393 |
0.705 |
|
2014 |
Sawant DV, Vignali DA. Once a Treg, always a Treg? Immunological Reviews. 259: 173-91. PMID 24712466 DOI: 10.1111/Imr.12173 |
0.484 |
|
2014 |
Sawant DV, Gravano DM, Vogel P, Giacomin P, Artis D, Vignali DA. Regulatory T cells limit induction of protective immunity and promote immune pathology following intestinal helminth infection. Journal of Immunology (Baltimore, Md. : 1950). 192: 2904-12. PMID 24532574 DOI: 10.4049/Jimmunol.1202502 |
0.466 |
|
2013 |
Hua L, Yao S, Pham D, Jiang L, Wright J, Sawant D, Dent AL, Braciale TJ, Kaplan MH, Sun J. Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection. Journal of Virology. 87: 11884-93. PMID 23986597 DOI: 10.1128/Jvi.01461-13 |
0.655 |
|
2013 |
Hollister K, Kusam S, Wu H, Clegg N, Mondal A, Sawant DV, Dent AL. Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model. Journal of Immunology (Baltimore, Md. : 1950). 191: 3705-11. PMID 23980208 DOI: 10.4049/Jimmunol.1300378 |
0.704 |
|
2013 |
Sawant DV, Wu H, Kaplan MH, Dent AL. The Bcl6 target gene microRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway. Molecular Immunology. 54: 435-42. PMID 23416424 DOI: 10.1016/J.Molimm.2013.01.006 |
0.633 |
|
2012 |
Sawant DV, Sehra S, Nguyen ET, Jadhav R, Englert K, Shinnakasu R, Hangoc G, Broxmeyer HE, Nakayama T, Perumal NB, Kaplan MH, Dent AL. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. Journal of Immunology (Baltimore, Md. : 1950). 189: 4759-69. PMID 23053511 DOI: 10.4049/Jimmunol.1201794 |
0.687 |
|
2010 |
Mondal A, Sawant D, Dent AL. Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages. Journal of Immunology (Baltimore, Md. : 1950). 184: 4123-32. PMID 20212093 DOI: 10.4049/Jimmunol.0901242 |
0.705 |
|
2009 |
Kusam S, Munugalavadla V, Sawant D, Dent A. BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells International Journal of Cancer. 125: 977-981. PMID 19405121 DOI: 10.1002/Ijc.24450 |
0.598 |
|
Show low-probability matches. |